anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Title

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 303,780
Current window 229,051-229,080
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all
18 30 60

Component

229,051-229,080 of 303,780

filter-aware
15
The slide uses a matrix structure to compare clinical and commercial viability for three indications.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit
16
The slide uses a circular/arc layout to categorize assets into 'Immunology Innovation Program', 'Pipeline', and 'VYVGART Opportunity'.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit
17
The slide uses an infinity-loop style diagram to connect three key pillars of the drug's value proposition.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit
19
The slide uses a central quote to humanize the clinical problem and market opportunity.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit
20
The slide uses an infinity-loop style diagram to represent a continuous process or interconnected concepts.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit
21
The slide uses two distinct scientific data visualizations: a longitudinal weight study in mice and a bar chart showing muscle contraction fidelity in an NMJ-on-a-chip model.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
22
The slide uses a circular/concentric layout to categorize assets into 'Immunology Innovation Program', 'Pipeline', and 'VYVGART Opportunity'.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
24
argenx SE | Investor Conference Presentation Deck | 27 slidesargenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
25
The slide uses a bar chart to show growth and two tables for financial summaries.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
27
argenx SE | Investor Conference Presentation Deck | 27 slidesargenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations 1 hit
01
Slide 1
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Humble Origins1 hit
02
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Humble Origins1 hit
03
The slide uses a combination of big numbers, process diagrams for strategy, and a mix of donut and bar charts for revenue analysis.AstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Humble Origins1 hit
07
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
10
The slide features a scientific illustration of cellular interaction on the left and the business unit name with icons on the right.AstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Rising Success1 hit
15
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · The BreakthroughLoop · Cost Of Inaction1 hit
18
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
22
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations 1 hit
23
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations 1 hit
24
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations 1 hit
25
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations 1 hit
26
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations 1 hit
01
Slide 1
Includes company logo, mission statement, and date.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
02
Page number 02 in top right corner.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
03
Slide 03 of the deck.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide uses a Gantt-style visualization to show drug development progress across Preclinical, Phase 1, Phase 2, and Phase 3 stages.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a blue-tinted portrait to evoke a clinical or therapeutic context.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The slide uses a timeline-based process diagram to illustrate the clinical trial flow.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide features a stylized portrait of a person, likely a patient or representative, within a circular frame.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide cites a third-party study (Palhano-Fontes et al.) as proxy evidence for DMT efficacy.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit